Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING LLC
PURITAN MEDICAL
GLOBETECH PUBLISHING LLC

New Electronic Pipette Designed for Accuracy and Comfort

By BiotechDaily International staff writers
Posted on 30 Jul 2013
A new line of electronic pipettes ensures error-free and comfortable pipetting even when performing repetitive routine procedures.

The INTEGRA Biosciences AG (Zizers, Switzerland) PIPETBOY pro weighs only 190 grams and was ergonomically designed for a comfortable fit in order to reduce the labor involved in prolonged pipetting tasks.

The PIPETBOY pro is a precision instrument that enables accurate liquid transfer at variable speeds that is controlled by finger pressure on the pipette's trigger. The user can dispense liquids drop-by-drop with slight pressure on the trigger, or, by fully pressing on the trigger, engage the powerful pump motor to quickly empty the pipette. Accurate and reliable results can be achieved quickly even by occasional users at pipetting speeds of up to 12 milliliters per second.

INTEGRA, a leading supplier of high-quality laboratory tools for liquid handling, media preparation, sterilization, and cell cultivation, has added a clever innovation to the PIPETBOY pro. The pipette is outfitted with an integral white LED light that provides strong illumination of the area around the pipette, ensuring accurate pipetting and preventing eyestrain.

Related Links:

INTEGRA Biosciences AG



Channels

Genomics/Proteomics

view channel
Image: Cholesterol–shown here in hamster ovary cells—is a building block of steroid hormones that trigger puberty and support pregnancy (Photo courtesy of Dr. D. Ory, Washington University School of Medicine).

Cholesterol Trafficking in the Mouse Embryo Is Regulated by a snoRNA

Cellular cholesterol trafficking in mouse embryos was found to be regulated by U17 snoRNA. Small nucleolar RNAs (snoRNAs) are a class of small RNA molecules that primarily guide chemical modifications... Read more

Business

view channel

License Agreement to Promote Development of Therapeutic CDK Inhibitors

A license agreement has been signed that was designed to promote the development and commercialization of a series of highly-selective cyclin-dependent kinase 7 (CDK7) inhibitors for the treatment of cancer, inflammation, and viral infections. Cyclin-dependent kinases (CDKs) play a pivotal role in cell cycle control... Read more
 
Copyright © 2000-2015 Globetech Media. All rights reserved.